Applied tariffs
Simple average MFN applied
2025
*
5.1 %
Trade-weighted MFN average
2024
*
3.0 %
Share of MFN duty-free
2025
29.0 %
Bound tariffs
Simple average bound
*
5.0 %
Binding coverage
100.0 %
Share of bound duty-free
29.2 %
Imports
Total imports: 2,782,558.3 million USD in 2024
Imports by partner
China
21.1 %
587,048.1
million USD
United States of America
14.2 %
395,604.9
million USD
United Kingdom
6.7 %
186,975.7
million USD
Switzerland
6.1 %
168,927.1
million USD
Türkiye
3.9 %
107,890.0
million USD
Norway
3.1 %
86,664.5
million USD
India
3.1 %
85,480.5
million USD
Korea, Republic of
2.7 %
75,227.0
million USD
Japan
2.6 %
72,884.4
million USD
Other Countries, n.e.s.
2.2 %
61,803.6
million USD
Rest of the World
34.3 %
954,052.5
million USD
Imports by products HS 2022
270900
Petroleum oils and oils obtained from bituminous minerals, crude
10.3 %
286,028.5
million USD
271019
Medium oils and preparations, of petroleum or bituminous minerals, not containing biodiesel, n.e.s.
2.3 %
63,219.9
million USD
999999
Unspecified products
1.8 %
48,745.4
million USD
300490
Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones or steroids used as hormones, alkaloids, provitamins, vitamins, their derivatives, antimalarial active principles and blinded clinical trial kits)
1.7 %
48,575.6
million USD
851713
Smartphones for wireless networks
1.6 %
44,953.8
million USD
271121
Natural gas in gaseous state
1.5 %
40,938.9
million USD
271111
Natural gas, liquefied
1.4 %
39,639.6
million USD
293399
Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, and lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl loflazepate "INN", fludiazepam "INN", flunitrazepam "INN", flurazepam "INN", halazepam "INN", lorazepam "INN", lormetazepam "INN", mazindol "INN", medazepam "INN", midazolam "INN", nimetazepam "INN", nitrazepam "INN", nordazepam "INN", oxazepam "INN", pinazepam "INN", prazepam "INN", pyrovalerone "INN", temazepam "INN", tetrazepam "INN" and triazolam "INN", salts thereof and azinphos-methyl "ISO")
1.2 %
34,200.5
million USD
851762
Machines for the reception, conversion and transmission or regeneration of voice, images or other data, incl. switching and routing apparatus (excl. telephone sets, telephones for cellular networks or for other wireless networks)
1.2 %
32,679.2
million USD
847130
Data-processing machines, automatic, portable, weighing <= 10 kg, consisting of at least a central processing unit, a keyboard and a display (excl. peripheral units)
1.2 %
32,113.3
million USD
Rest of the products
75.9 %
2,111,463.5
million USD
Exports
Total exports: 3,005,525.5 million USD in 2024
Exports by destination
United States of America
20.8 %
626,292.4
million USD
United Kingdom
13.1 %
394,701.2
million USD
China
8.5 %
256,837.0
million USD
Switzerland
8.2 %
246,259.0
million USD
Türkiye
4.1 %
122,155.5
million USD
Other Countries, n.e.s.
2.9 %
86,807.9
million USD
Japan
2.6 %
78,267.7
million USD
Norway
2.3 %
70,308.7
million USD
Korea, Republic of
2.3 %
68,368.1
million USD
Mexico
1.9 %
57,927.8
million USD
Rest of the World
33.2 %
997,600.1
million USD
Exports by products HS 2022
300490
Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones or steroids used as hormones, alkaloids, provitamins, vitamins, their derivatives, antimalarial active principles and blinded clinical trial kits)
5.4 %
161,643.6
million USD
870323
Motor cars and other motor vehicles principally designed for the transport of <10 persons, incl. station wagons and racing cars, with only spark-ignition internal combustion reciprocating piston engine of a cylinder capacity > 1.500 cm³ but <= 3.000 cm³ (excl. vehicles for travelling on snow and other specially designed vehicles of subheading 8703.10)
3.1 %
92,800.0
million USD
300215
Immunological products, put up in measured doses or in forms or packings for retail sale (excl. diagnostic reagents)
2.1 %
64,468.2
million USD
999999
Unspecified products
2.0 %
60,911.2
million USD
271012
Light oils and preparations, of petroleum or bituminous minerals which >= 90% by volume "incl. losses" distil at 210°C "ASTM D 86 method" (excl. containing biodiesel)
2.0 %
59,320.0
million USD
880240
Aeroplanes and other powered aircraft of an of an unladen weight > 15.000 kg (excl. helicopters, dirigibles and unmanned of heading 8806)
1.6 %
49,176.2
million USD
271019
Medium oils and preparations, of petroleum or bituminous minerals, not containing biodiesel, n.e.s.
1.5 %
45,155.2
million USD
870380
Motor cars and other motor vehicles principally designed for the transport of <10 persons, incl. station wagons and racing cars, with only electric motor for propulsion (excl. vehicles for travelling on snow and other specially designed vehicles of subheading 8703.10)
1.5 %
43,701.1
million USD
848620
Machines and apparatus for the manufacture of semiconductor devices or of electronic integrated circuits
1.2 %
36,000.5
million USD
300241
Vaccines for human medicine
0.8 %
24,518.2
million USD
Rest of the products
78.8 %
2,367,831.2
million USD
Preferential regimes provided by European Union
Loading...
European Union as a beneficiary based on other economies reported preferential regimes
Loading...